4.5 Article

Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription

Journal

MOLECULAR AND CELLULAR BIOLOGY
Volume 23, Issue 24, Pages 9081-9093

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.23.24.9081-9093.2003

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA095731, R01 CA 95731] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM053874, R01 GM 53874, F32 GM 70690, F32 GM070690, R01 GM063773, R01 GM 63773] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [R01CA095731] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070690, R01GM063773, R01GM053874] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Smad6 and Smad7 are inhibitory Smads induced by transforming growth factor P-Smad signal transduction pathways in a negative-feedback mechanism. Previously it has been thought that inhibitory Smads bind to the type I receptor and block the phosphorylation of receptor-activated Smads, thereby inhibiting the initiation of Smad signaling. Conversely, few studies have suggested the possible nuclear functions of inhibitory Smads. Here, we present compelling evidence demonstrating that Smad6 repressed bone morphogenetic protein-induced Id1 transcription through recruiting transcriptional corepressor C-terminal binding protein (CtBP). A consensus CtBP-binding motif, PLDLS, was identified in the linker region of Smad6. Our findings show that mutation in the motif abolished the Smad6 binding to CtBP and subsequently its repressor activity of transcription. We conclude that the nuclear functions and physical interaction of Smad6 and CtBP provide a novel mechanism for the transcriptional regulation by inhibitory Smads.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available